NCT04312022

Brief Summary

The purpose of this study is to investigate the impacts of a combined berry extract supplement (hawthorn berry, tart cherry, and bromelain extracts) on total antioxidant capacity, endothelial function, blood pressure, oxygen utility capacity, and fatigue index in healthy young adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 17, 2020

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

February 6, 2024

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

March 13, 2020

Results QC Date

May 5, 2023

Last Update Submit

February 2, 2024

Conditions

Keywords

anthocyaninendothelial functionoxygenvascular functionblood pressureantioxidant

Outcome Measures

Primary Outcomes (1)

  • Endothelial Function

    Endothelial function was measured using flow-mediated dilation in percents (%). A higher value represents a better outcome. Scale range for endothelial function is approximately 8-12% for healthy populations.

    1 day

Secondary Outcomes (8)

  • Systolic Blood Pressure

    1 day

  • Diastolic Blood Pressure

    1 day

  • Oxygen Utility Capacity (Tissue Saturation Index)

    1 day

  • Exercise Fatigue Index During Leg Extension

    1 day

  • Exercise Fatigue Index During Leg Flexion

    1 day

  • +3 more secondary outcomes

Study Arms (2)

Berry extract intake, then Placebo

EXPERIMENTAL

Participants received a single dose of berry extract supplement (hawthorn berry extract, tart cherry extract, and bromelain). After a washout period of 2 weeks, they then received a single dose of the placebo (flour capsule).

Dietary Supplement: Berry extract

Placebo intake, then Berry extract intake

PLACEBO COMPARATOR

Participants received a single dose of placebo (flour capsule). After a washout period of 2 weeks, they then received a single dose of berry extract supplement (hawthorn berry extract, tart cherry extract, and bromelain).

Other: Placebo

Interventions

Berry extractDIETARY_SUPPLEMENT

Berry extract supplement (hawthorn berry extract, tart cherry extract, bromelain)

Berry extract intake, then Placebo
PlaceboOTHER

Placebo (flour capsule)

Placebo intake, then Berry extract intake

Eligibility Criteria

Age19 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • otherwise healthy adult

You may not qualify if:

  • cardiovascular disease
  • neurological disorder
  • metabolic disorder
  • respiratory disorder
  • renal diseases
  • musculoskeletal injury
  • bleeding disorder
  • allergy to fruit
  • pregnant/breast feeding
  • taking daily medication (prescription or over-the-counter)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nebraska at Omaha

Omaha, Nebraska, 68182, United States

Location

MeSH Terms

Interventions

Fruit

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Results Point of Contact

Title
Song-Young Park
Organization
University of Nebraska at Omaha

Study Officials

  • Song-Young Park, PhD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Neither the subject nor the investigators were aware of the study assignments, which were assigned by a lab member not directly involved in the measurements of the research.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Randomized, placebo-controlled, crossover design (1:1)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2020

First Posted

March 17, 2020

Study Start

November 4, 2018

Primary Completion

March 29, 2019

Study Completion

June 13, 2019

Last Updated

February 6, 2024

Results First Posted

February 6, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations